August 13, 2008
Khorrami, Pollard &Amp; Abir, LLP, Files Wrongful Death Suit Against Type II Diabetes Drug Makers
A wrongful death suit was filed against GlaxoSmithKline, SmithKline Beecham, and McKesson Corporation in California Superior Court, charging that Avandia, prescribed for Type 2 Diabetes, led to heart attacks, congestive heart failure and other fatal cardiovascular injuries in seven individuals.
The suit, brought by Khorrami, Pollard & Abir and Kabateck Brown Kellner, LLP, was filed on behalf of the victims' seven surviving spouses, including Los Angeles, CA, and Costa Mesa, CA, residents.
The suit contends that GlaxoSmithKline, SmithKline Beecham and McKesson knew Avandia increased the risk of adverse cardiovascular events but failed to adequately warn patients, physicians or the public in general.
Avandia received FDA approval for the treatment of Type 2 Diabetes in 1999. Since then, Avandia has been prescribed to approximately six million people in the United States and was ranked as GlaxoSmithKline's second largest selling drug, with sales more than $2 billion in 2006.
In 2005, GSK performed an analysis of multiple Avandia trials but did not share the complete results with the FDA until August 2006. The results showed that patients consuming Avandia had a 31% increased risk of adverse cardiovascular events such as heart attacks.
In 2007, Dr. Steven E. Nissen, a cardiologist with the Cleveland Clinic, published a study in the New England Journal of Medicine which showed that those taking Avandia have a 43% higher risk of heart attack than those taking other diabetes medications or no medication at all.
Even after the trials that had been performed and Dr. Nissen's study, the Defendants still did nothing to adequately warn or remedy the dangers associated with the consumption of Avandia.
"This is yet another example of a very broken FDA. The justice system remains the last line of defense for ordinary citizens," says Shawn Khorrami, one of the lawyers representing Ms. Rhodes. "We intend to protect our clients where the FDA failed them."
More information, contact: Shawn Khorrami 310-308-9423 Law Offices of Khorrami, Pollard & Abir 444 S. Flower Street 33rd Floor Los Angeles, CA 213.596.6000
SOURCE: Khorrami, Pollard & Abir